The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
AURX · Healthcare · Shallow moat
Doesn't clear the bar
The businessTrend component abstained: Fewer than two aligned fiscal years of revenue and diluted EPS are available; the filing history does not contain a measurable trend. The other four 20% weights were renormalized over the scored 80%.
| Measure | ELUT | SNYR | TMCI | AURX |
|---|---|---|---|---|
| Moat Score (0–100) | 42 (highest) | 42 (highest) | 42 (highest) | 42 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 40 | 0 | 60 (highest) | — |
| Pricing power | 72 | 85 | 100 (highest) | 70 |
| Returns on capital | 0 | 75 (highest) | 0 | 0 |
| Balance-sheet safety | 55 (highest) | 28 | 28 | 55 (highest) |
| Capital allocation | 44 (highest) | 24 | 24 | 44 (highest) |
| No price data | No price data | No price data | No price data | |
| Market cap | Not reported | $1.9M | Not reported | $49.1M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |